BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Tonlamarsen readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Tonlamarsen\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07511361-531@assetmemo.bio
DTSTAMP:20261121T005710Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Tonlamarsen: Phase 2 readout est. (NCT07511361)
DESCRIPTION:Tonlamarsen\, phase 2\, Hypertension.\nStudy: Study of Efficacy
  and Safety of Tonlamarsen in Participants With a Recent Hospitalization a
 nd a Concurrent Episode of Acute Severe Hypertension\nEstimated primary co
 mpletion: December 2026. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/tonlamarsen#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT07511361
URL:https://assetmemo.bio/drug/tonlamarsen#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
